Amphastar P (AMPH) Stock Analysis

Amphastar P (AMPH) is a publicly traded company in the HEALTHCARE sector. It trades at $18.45, carries a market capitalization of $812.19M, a price-to-earnings ratio of 11.10. This page summarizes the public market data, fundamentals, and frequently asked questions for AMPH, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

• Price: $18.45
• Market Cap: $812.19M
• P/E Ratio: 11.10
• EPS: $1.66
• 52-Week High: $31.26
• 52-Week Low: $16.64

Market Sentiment

Amphastar P currently has a Bullish sentiment score of 0.37.

About Amphastar P

Amphastar Pharmaceuticals, Inc. is a prominent specialty pharmaceutical company dedicated to the development, manufacturing, and commercialization of both generic and proprietary injectable, inhalation, and intranasal products. Primarily serving the U.S. market while expanding internationally in regions such as China and France, Amphastar leverages its advanced research and development expertise alongside a comprehensive manufacturing infrastructure to target critical therapeutic areas. With ...

GNG Research Analysis

GNG Research scores Amphastar P (AMPH) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for AMPH.

Frequently Asked Questions

Does AMPH pay dividends?

Amphastar P (AMPH) does not currently pay a regular dividend.

What is AMPH's P/E ratio?

Amphastar P has a price-to-earnings (P/E) ratio of 11.10.

What is AMPH's market cap?

Amphastar P (AMPH) has a market capitalization of $812.19M with a current stock price of $18.45.